R

Rocket Pharmaceuticals
D

RCKT

8.02000
USD
0.16
(2.04%)
مغلق
حجم التداول
74,356
الربح لكل سهم
-2
العائد الربحي
-
P/E
-3
حجم السوق
856,420,560
أصول ذات صلة
AAPL
AAPL
-2.225
(-1.07%)
205.245 USD
AMZN
AMZN
3.770
(2.02%)
189.950 USD
BA
BA
1.660
(0.90%)
185.390 USD
GOOG
GOOG
1.700
(1.04%)
165.760 USD
LMT
LMT
-5.04
(-1.06%)
472.68 USD
MSFT
MSFT
7.83
(1.83%)
435.01 USD
NOC
NOC
4.69
(0.96%)
491.62 USD
S
SPCE
0.02000
(0.70%)
2.89000 USD
TSLA
TSLA
6.17
(2.20%)
287.24 USD
المزيد
الأخبار المقالات

العنوان: Rocket Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.